CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-05-13 | WINSTEAD DWIGHT Director | Option exercise | +1,405 | $2.69 | $4K | 1,405 |
| 2010-05-13 | WINSTEAD DWIGHT Director | Sale | −1,405 | $19.20 | $27K | 0 |
| 2010-05-13 | WINSTEAD DWIGHT Director | Option exercise · stock option (right to buy) | −1,405 | 15,595 | ||
| 2010-03-23 | PARKER H STEWART Director | Grant or award · stock option (right to buy) | +4,723 | 4,723 | ||
| 2010-03-23 | GOLDSTEIN JACK Director | Grant or award · stock option (right to buy) | +4,723 | 4,723 | ||
| 2010-01-28 | Cormack Scott Daniel President and CEO | Option exercise | +7,077 | $3.89 | $28K | 8,092 |
| 2010-01-28 | Cormack Scott Daniel President and CEO | Option exercise · stock option (right to buy) | −7,077 | 0 | ||
| 2009-12-31 | JACOBS CINDY EVP, CMO | Grant or award · employee stock option (right to buy) | +12,000 | $22.28 | $267K | 12,000 |
| 2009-12-31 | Cormack Scott Daniel President and CEO | Grant or award · employee stock option (right to buy) | +25,000 | $22.28 | $557K | 25,000 |
| 2009-12-31 | Anderson Stephen Charles CFO and Secretary | Grant or award · employee stock option (right to buy) | +8,000 | $22.28 | $178K | 8,000 |
| 2009-12-22 | Brady Patrick Robert Director | Option exercise | +5,359 | $2.69 | $14K | 5,359 |
| 2009-12-22 | Brady Patrick Robert Director | Option exercise | +11,641 | $2.69 | $31K | 17,000 |
| 2009-12-22 | Brady Patrick Robert Director | Option exercise | +4,130 | $7.25 | $30K | 21,130 |
| 2009-12-22 | Brady Patrick Robert Director | Option exercise · Stock Option (Right to Buy0 | −5,359 | 0 | ||
| 2009-12-22 | Brady Patrick Robert Director | Option exercise · Stock Option (Right to Buy0 | −11,641 | 0 | ||
| 2009-12-22 | Brady Patrick Robert Director | Option exercise · Stock Option (Right to Buy0 | −4,130 | 0 | ||
| 2009-07-10 | Cormack Scott Daniel President and CEO | Option exercise | +871 | $3.89 | $3K | 1,886 |
| 2009-07-10 | Cormack Scott Daniel President and CEO | Gift | −871 | 1,015 | ||
| 2009-07-10 | Cormack Scott Daniel President and CEO | Gift | +871 | 25,680 | ||
| 2009-07-09 | Cormack Scott Daniel President and CEO | Option exercise · stock option (right to buy) | −871 | 0 |
Page 39 of 46 · 905 trades